We do often talk about pharmaceutical companies aiming to achieve “reimbursement” for the products, but what does that actually mean in real practice? Who is paying who?
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
We do often talk about pharmaceutical companies aiming to achieve “reimbursement” for the products, but what does that actually mean in real practice? Who is paying who?